ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

NRXS vs OM // PIOTROSKI F-SCORE QUALITY

Neuraxis Inc. (NYSE) VS. Outset Medical Inc. (NASDAQ) • 15-METRIC TALLY: NRXS 3 — OM 4
▲ PIOTROSKI F-SCORE QUALITY LEADER: OM
piotroski-score
6/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NRXS VS. OM) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC NRXS OM SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 84.20% 39.10% +45.10 NRXS /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -28.00% -7.00 OM /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -6.82% — — TIE /fcf-yield <GO>
Operating Margin -60.00% -55.80% -4.20 OM /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) 32.90% 5.10% +27.80 NRXS /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 1.88 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality ACTIVE 5/9 6/9 -1.00 OM /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 54.9 55.8 -0.90 OM /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $94.8M $78.8M $16.1M NRXS /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR NRXS REV OM REV NRXS GROSS % OM GROSS % NRXS FCF OM FCF
FY 2025 $3.6M $119.5M 84.2% 39.1% -$6.5M -$47.1M
FY 2024 $2.7M $113.7M 86.5% 33.9% -$6.1M -$117.2M
FY 2023 $2.5M $130.4M — — -$6.7M -$131.4M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NRXS // BETA —
OM // BETA —